<DOC>
	<DOCNO>NCT01350609</DOCNO>
	<brief_summary>Randomized , open label , single dose , 2-way crossover study investigate bioequivalence new fix dose combination ( FDC ) tablet nifedipine GITS candesartan correspond loose combination feed condition .</brief_summary>
	<brief_title>Pivotal Bioequivalence FDC Nifedipine / Candesartan v . Loose Combination Single Components , Fed</brief_title>
	<detailed_description>Clinical pharmacology</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>The informed consent form must sign study specific test procedures do Confirmation subject 's health insurance coverage prior first screen visit Healthy male subject Ethnicity : Caucasian Age : 18 45 year ( inclusive ) first screen visit Body mass index ( BMI ) equal 18 , equal 29.9 kg / mÂ² Ability understand follow studyrelated instruction Suspicion drug alcohol abuse Regular daily consumption 1 L xanthincontaining beverage Intake food beverage contain grapefruit within 2 week prior first study drug administration ( applies pomelos St. John 's Wort ) Use medication within 4 week prior first study drug administration could interfere investigational product ( e.g . CYP3A inhibitor CYP3A inducer ) examples CYP3A inhibitor : erythromycin , inhibitor human HIV protease ( e.g . ritonavir , saquinavir ) , amiodarone , diltiazem , verapamil , fluconazole , itraconazole , ketoconazole , clarithromycin , telithromycin , nefazodon , cimetidine ; examples CYP3A inducer : rifampicin , carbamazepin , phenytoin , phenobarbital , product contain St. John 's Wort ; Systolic blood pressure 116 145 mmHg ( least 15 min supine ) At first screen visit Diastolic blood pressure 95 mmHg ( least 15 min supine ) Heart rate 45 95 beat / min ( least 15 min supine ) first screen visit Clinically relevant finding physical examination Positive urine drug screen alcohol breath test Exclusion period study simultaneous participation clinical study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>essential hypertension , blood pressure , nifedipine , candesartan , FDC</keyword>
</DOC>